Bernstein: Two firms courting Coloplast rival
The battle for Coloplast rival Smith & Nephew will be fought between two players with very different reasons for taking an interest in the company, says research firm Bernstein. But Smith & Nephew is fighting to remain independent.
BY STEFAN SINGH KAILAY
Either Stryker Corporation or Johnson & Johnson will become the new owner of global Coloplast rival Smith & Nephew – and Stryker is leading the chase.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Political unrest could accelerate acquisitions
For abonnenter
”We keep an eye on them, same as always”
For abonnenter
Is Coloplast going for its rival’s spoils?
For abonnenter
